妊娠期糖尿病
医学
糖尿病前期
小RNA
糖尿病
怀孕
生物信息学
后代
表观遗传学
妊娠期
基因
内科学
内分泌学
2型糖尿病
遗传学
生物
作者
Ilona Juchnicka,Mariusz Kuźmicki
出处
期刊:Ginekologia Polska
[VM Media Sp zo.o. - VMGroup SK]
日期:2021-08-30
卷期号:92 (8): 579-582
被引量:1
标识
DOI:10.5603/gp.a2021.0121
摘要
Gestational Diabetes Mellitus (GDM) is a metabolic disorder that is considered a prediabetes state. According to the International Diabetes Federation every year an increase in the number of women diagnosed with gestational diabetes is being noticed. It is known that GDM can cause many complications during pregnancy and labor. What is more, women with GDM history and their offspring are at risk of developing diabetes in the future. A new factor in the pathogenesis of GDM is epigenetics, which is described as changes in gene expression without directly modifying the DNA sequence. One of its regulating mechanisms is based on microRNA (miRNA). A small non-coding RNA sequence that has an influence on protein formation by suppressing gene expression. A better understanding of the miRNA's function could potentially lead to their usage as potential new biomarkers or treatment targets. In this article we review the most significant miRNA molecules in gestational diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI